ArticleFrontiers in molecular neuroscience2024
Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targets.
Nalaka Wijekoon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.